News brief
On 2024/10/10, The Information reported that Abridge, a US healthcare AI company, was raising USD 250 million at a USD 1 billion valuation, with approximately USD 50 million in annual revenue. It uses AI to transcribe doctor-patient conversations and automatically generate medical records, representing Elad Gil's latest investment in healthcare AI.
Connected profiles
AbridgeCompanies ↗Bessemer Venture PartnersInvestors ↗California Health Care FoundationInvestors ↗CapitalGInvestors ↗Elad GilInvestors ↗IVPInvestors ↗NVIDIAInvestors ↗
Explore
Sources · 1Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
- www.theinformation.com ↗Published Oct 10, 2024
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
2024年10月10日，据The Information报道，美国医疗AI公司Abridge正筹集2.5亿美元融资，估值达10亿美元，当前年收入约5000万美元。该公司利用AI转录医患对话并自动生成病历，是Elad Gil在医疗AI领域的最新布局。